Literature DB >> 18032231

Treatment options for sleep disturbances during alcohol recovery.

J Todd Arnedt1, Deirdre A Conroy, Kirk J Brower.   

Abstract

Sleep disturbances are extremely common in the early stages of recovery from alcohol dependence and may persist for several months despite continued abstinence. Studies indicate that sleep disturbances independently increase the risk for relapse to alcohol, suggesting that targeting these problems during recovery may support continued abstinence. However, there is limited information in the addiction literature about available and effective treatments for sleep disturbances in recovering alcoholic patients. The primary goals of this article are to describe the phenomenology of sleep disturbances during recovery from alcohol dependence, to outline the evidence linking sleep problems with alcohol relapse, and to describe available pharmacological and nonpharmacological treatment options, including the evidence regarding their efficacy in recovering alcoholic patients. Recommendations for future research are provided along with special considerations for treating insomnia in this population, including avoiding cross-dependent sedatives, such as benzodiazepines and benzodiazepine receptor agonists (BzRAs).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032231      PMCID: PMC2936493          DOI: 10.1300/J069v26n04_06

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  118 in total

1.  Impaired sleep in alcohol misusers and dependent alcoholics and the impact upon outcome.

Authors:  J H Foster; T J Peters
Journal:  Alcohol Clin Exp Res       Date:  1999-06       Impact factor: 3.455

2.  Acute akathisia associated with quetiapine use.

Authors:  Glenn Catalano; John W Grace; Maria C Catalano; Miguel J Morales; Laura M Cruse
Journal:  Psychosomatics       Date:  2005 Jul-Aug       Impact factor: 2.386

Review 3.  A review of the evidence for the efficacy and safety of trazodone in insomnia.

Authors:  Wallace B Mendelson
Journal:  J Clin Psychiatry       Date:  2005-04       Impact factor: 4.384

4.  Association of sleep disturbance with chronicity and remission of alcohol dependence: data from a population-based prospective study.

Authors:  Rosa M Crum; Daniel E Ford; Carla L Storr; Ya-Fen Chan
Journal:  Alcohol Clin Exp Res       Date:  2004-10       Impact factor: 3.455

5.  Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II.

Authors:  T Roth; S Ancoli-Israel
Journal:  Sleep       Date:  1999-05-01       Impact factor: 5.849

6.  Insomnia in primary care patients.

Authors:  T Shochat; J Umphress; A G Israel; S Ancoli-Israel
Journal:  Sleep       Date:  1999-05-01       Impact factor: 5.849

7.  Adolescents, substance abuse, and the treatment of insomnia and daytime sleepiness.

Authors:  Richard R Bootzin; Sally J Stevens
Journal:  Clin Psychol Rev       Date:  2005-07

8.  Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.

Authors:  C M Morin; C Colecchi; J Stone; R Sood; D Brink
Journal:  JAMA       Date:  1999-03-17       Impact factor: 56.272

9.  Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan.

Authors:  Maurice M Ohayon; Mary A Carskadon; Christian Guilleminault; Michael V Vitiello
Journal:  Sleep       Date:  2004-11-01       Impact factor: 5.849

10.  Polysomnographic and subjective sleep predictors of alcoholic relapse.

Authors:  K J Brower; M S Aldrich; J M Hall
Journal:  Alcohol Clin Exp Res       Date:  1998-11       Impact factor: 3.455

View more
  29 in total

Review 1.  Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework.

Authors:  George F Koob; Ian M Colrain
Journal:  Neuropsychopharmacology       Date:  2019-06-24       Impact factor: 7.853

2.  Dose-response study of chronic alcohol induced changes in sleep patterns in rats.

Authors:  Sanjib Mukherjee; Morvarid Kazerooni; Steven M Simasko
Journal:  Brain Res       Date:  2008-03-07       Impact factor: 3.252

3.  Partial K-Complex Recovery Following Short-Term Abstinence in Individuals with Alcohol Use Disorder.

Authors:  Adrian R Willoughby; Massimiliano de Zambotti; Fiona C Baker; Ian M Colrain
Journal:  Alcohol Clin Exp Res       Date:  2015-07-14       Impact factor: 3.455

4.  Learned motivation drives circadian physiology in the absence of the master circadian clock.

Authors:  Oliver Rawashdeh; Shannon J Clough; Randall L Hudson; Margarita L Dubocovich
Journal:  FASEB J       Date:  2016-10-12       Impact factor: 5.191

5.  Prevalence and correlates of sleep-related problems in adults receiving medical cannabis for chronic pain.

Authors:  James A Cranford; J Todd Arnedt; Deirdre A Conroy; Kipling M Bohnert; Carrie Bourque; Frederic C Blow; Mark Ilgen
Journal:  Drug Alcohol Depend       Date:  2017-09-09       Impact factor: 4.492

6.  Cognitive-behavioral therapy for insomnia in alcohol dependent patients: a randomized controlled pilot trial.

Authors:  J Todd Arnedt; Deirdre A Conroy; Roseanne Armitage; Kirk J Brower
Journal:  Behav Res Ther       Date:  2011-02-15

7.  Sleep homeostasis in alcohol-dependent, depressed and healthy control men.

Authors:  Kirk J Brower; Robert Hoffmann; Deirdre A Conroy; J Todd Arnedt; Roseanne Armitage
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-02-11       Impact factor: 5.270

8.  Abstinence-related changes in sleep during treatment for cocaine dependence.

Authors:  G A Angarita; S V Canavan; E Forselius; A Bessette; B Pittman; P T Morgan
Journal:  Drug Alcohol Depend       Date:  2013-11-17       Impact factor: 4.492

9.  Buprenorphine disrupts sleep and decreases adenosine concentrations in sleep-regulating brain regions of Sprague Dawley rat.

Authors:  Elizabeth A Gauthier; Sarah E Guzick; Chad M Brummett; Helen A Baghdoyan; Ralph Lydic
Journal:  Anesthesiology       Date:  2011-10       Impact factor: 7.892

10.  Chronic alcohol exposure reduces acetylated histones in the sleep-wake regulatory brain regions to cause insomnia during withdrawal.

Authors:  Rishi Sharma; Pradeep Sahota; Mahesh M Thakkar
Journal:  Neuropharmacology       Date:  2020-09-19       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.